Back
Speaker illustration

undefined undefined undefined

Sessions Presentations Articles

Risk factors (2)

Event: ESC Congress 2025

Topic: Cardiovascular Risk Assessment

Session type: Moderated ePosters

Access
Like
Thumbnail

Diabetes, obesity, and the heart

Event: ESC Congress 2024

Topic: Antidiabetic Pharmacotherapy

Session type: Moderated ePosters

Access
Like
Thumbnail

Great Debate: should we still target triglycerides to decrease cardiovascular risk?

Event: ESC Congress 2023

Topic: Lipids

Session type: Great Debates

Access
Like
Thumbnail

Are we achieving guideline-recommended low-density lipoprotein cholesterol (LDL-C) goals in real life?

Event: ESC Congress 2023

Topic: Lipid-Lowering Agents

Session type: Satellite Symposium

Access
Like
Thumbnail

Combination therapy at the heart of lipid lowering management

Event: ESC Preventive Cardiology 2023

Topic: Lipid-Lowering Agents

Session type: Satellite Symposium

Access
Like
Thumbnail

EAS Consensus on Lp(a) 2022 - what to measure, in whom to measure, how to interpret and what to do

Event: ESC Congress 2022

Topic: Lipids

Session type: Symposium

Access
Like
Thumbnail

Dyslipidemia Challenge - Closing the Gap Between Guidelines and Clinical Practice

Event: ESC Congress 2021 - The Digital Experience

Topic: PCSK9-Antagonists

Session type: Satellite Symposium

Access
Like
Thumbnail

Lipid lowering beyond LDL-cholesterol and statins

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacology and Pharmacotherapy

Session type: Cardiology Toolbox

Access
Like
Thumbnail

Managing patients with dyslipidaemia: how to tackle clinical inertia

Event: ESC Congress 2020

Topic: Drug therapy

Session type: Industry Q&A session

Access
Like
Thumbnail

Lipid Treatment in very high risk ASCVD patient

Event: ESC Congress 2019

Topic: Lipids

Session type: Symposium

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources